ABOUT
Achieve more perspective
At Aiosyn, we are committed to advancing precision pathology in cancer and kidney diseases through artificial intelligence. We develop software solutions that inject deep-learning algorithms into existing workflows to provide data-driven insights that ultimately improve patient outcomes.
With our AI-powered technology, we want to offer pathology labs and biopharma companies new perspectives to discover the most effective treatments while optimizing workflow efficiency.
Meet the team
We bring AI technology to patients
Aiosyn’s team is a unique mix of talented scientists, engineers, regulatory, medical and business professionals that aim to bring computational pathology technology to patients and doctors.
Meet the Team
Aiosyn is rooted in pathology
Aiosyn was founded as a spin-off from the Computational Pathology research group of Radboud University Medical Center, one of the front-runners in the field. We build upon 20+ years of research experience in the field of pathology and are proud to say that we are rooted in pathology practice. With our track-record in artificial intelligence and software engineering we bring research innovations into the hands of pathologists.
Our close connection to clinical practice allows us to build computational pathology solutions for and together with pathologists. We believe in the power of AI to empower pathologists and envision a world where AI is available everywhere, anytime.
See our Solutions
